Doctor Cinira Lefevre
Bristol-Myers Squibb, Rueil-Malmaison (France)
Which factors recorded during routine care predict treatment discontinuation of novel oral anticoagulants in patients with non-valvular atrial fibrillation?
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Clinical and epidemiological aspects (Atrial Fibrillation)
Session: Atrial Fibrillation - Clinical and epidemiological aspects
ESC 365 is supported by
